1 min read

AbSci Closes $15.4 M in Series D Funding to Accelerate Growth and Scale Disruptive Protein PrintingTM Technology, Announces Exclusive Co-Marketing Partnership with KBI Biopharma

3 min read

Press Release | ZyVersa Therapeutics to Advance Development of Its Lead Inflammasome Inhibitor with Selexis and KBI Biopharma’s Integrated Development Platform

5 min read

Press Release | KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board

3 min read

Press Release | CytoSen Therapeutics and KBI Biopharma Enter into Strategic Partnership to Manufacture NK Cells and Nanoparticles

KBI in the News | KBI boosts analytical services with Belgium expansion - via BioProcess International

KBI in the News | AdAlta secures key manufacturing agreements for AD-214

2 min read

Press Release | KBI Biopharma BVBA Opens in Leuven, Belgium, Offering Analytical Services to the European Market

3 min read

Press Release | ReForm Biologics and KBI Biopharma Announce Strategic Partnership to Improve Biopharmaceutical Formulations and Development

2 min read

Press Release | KBI Biopharma Acquires Elion Labs to Further Expand Industry-Leading Biophysical and Analytical Characterization Capabilities

2 min read

Press Release | KBI Biopharma Acquires Alliance Protein Laboratories, Expands Biophysical Characterization Capabilities